Order results by:
| Issue | Title | |
| Vol 15, No 3 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State | Abstract similar documents |
| I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova | ||
| "... atherosclerosis and osteoporosis. Currently, various groups of drugs for the treatment of osteoporosis have been ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... on bone mineral density and fractures associated with osteoporosis. The mechanisms of action of drugs ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... to recommend discussed cardiovascular drugs for prevention of osteoporosis and fractures, as well ..." | ||
| Vol 5, No 2 (2009) | POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh | ||
| "... osteoporosis (PO) and a arterial hypertension (HT). Material and methods. 45 women with PO, HT (1-2 stage ..." | ||
| Vol 19, No 5 (2023) | Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies | Abstract similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, T. T. Tsoriev, O. Yu. Isaykina, O. M. Drapkina | ||
| "... ) and osteoporosis and, in particular, their preclinical manifestations. Most of the papers on this issue ..." | ||
| Vol 16, No 6 (2020) | Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women | Abstract PDF (Eng) similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, M. A. Myagkova, V. E. Novikov, O. Yu. Isaykina, O. M. Drapkina | ||
| "... of development and progression of atherosclerosis and osteoporosis. Therefore, early examination of women ..." | ||
| Vol 19, No 1 (2023) | Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women | Abstract similar documents |
| O. Yu. Isaykina, I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, V. E. Novikov, T. T. Tsoriev | ||
| "... степень остеопороза (Т-критерий, МПК). Для ИА отмечена статистически значимая, но слабая отрицательная ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... , and the development of osteoporosis. The high prevalence of atrial fibrillation and osteoporosis in older age groups ..." | ||
| Vol 1, No 1 (2005) | DRUGS AND SMOKING | Abstract similar documents |
| J. V. Lukina | ||
| "... of drug treatment by affecting the course of different physiological processes and modifying ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... with elevated Lp(a) levels, as well as a range of pharmacotherapeutic drugs being developed to reduce its level ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... At present experimental and clinical data confirming efficacy of magnesium-containing drugs ..." | ||
| Vol 18, No 4 (2022) | Respiratory Muscle Strength in Patients with Coronary Heart Disease and Different Musculoskeletal Disorders | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, N. A. Galimova, K. E. Krivoshapova, O. L. Barbarash | ||
| Vol 17, No 3 (2021) | Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, K. E. Krivoshapova, V. L. Masenko, E. A. Wegner, А. N. Kokov, S. A. Pomeshkina, O. L. Barbarash | ||
| "... ); verification of osteopenia/osteoporosis according to the WHO criteria (2008); diagnosing osteosarcopenia ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... ) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application ..." | ||
| Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
| E. B. Babanskaya, L. V. Menshikova | ||
| "... Aim. To analyze the factors of medical choice in the prescription of medicinal drug (MD ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... влияния на исходы сердечно-сосудистых заболеваний. С этой точки зрения рассматриваются показания к ..." | ||
| Vol 21, No 1 (2025) | Assessment of self-treatment in terms of inappropriate prescribing registry | Abstract similar documents |
| S. Yu. Martsevich, V. V. Tsaregorodtseva, N. P. Kutishenko, Yu. V. Lukina, A. V. Zagrebelnyi, I. V. Mihailova, O. M. Drapkina | ||
| "... to 08/07/2024. The physician conducted an examination, assessed drug therapy, adherence ..." | ||
| Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
| "... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Обсуждают проблему применения варениклина у больных сердечно-сосудистыми заболеваниями. Результаты ..." | ||
| Vol 12, No 4 (2016) | Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension | Abstract similar documents |
| R. R. Kushkhova, A. G. Avtandilov | ||
| "... hemodynamics in patients with drug resistant hypertension (HT). Material and methods. In total, 120 patients ..." | ||
| Vol 18, No 5 (2022) | Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi | ||
| "... Aim. To identify and evaluate the nature and incidence of drug-related problems (DRPs ..." | ||
| Vol 6, No 6 (2010) | REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" | Abstract similar documents |
| A. A. Aleksandrov | ||
| "... The classic hypoglycemic agents include biguanides, sulfonylurea drugs, meglitinides, glitazones ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| Vol 15, No 5 (2019) | Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them | Abstract similar documents |
| N. V. Pyrikova, O. N. Antropova, I. V. Osipova | ||
| "... of medicines. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is one of the main methods of treating ..." | ||
| Vol 19, No 5 (2023) | Association of breast arterial calcification and carotid atherosclerosis as a marker of cardiovascular risk | Abstract similar documents |
| E. V. Bochkareva, E. K. Butina, N. Kh. Bayramkulova, I. V. Kim, O. V. Molchanova, E. M. Filichkina, E. B. Yarovaya, V. A. Metelskaya, O. M. Drapkina | ||
| "... ,2%, p=0,039) and osteoporosis (18,2% vs 6,1%, p=0,016) in history. In women with BAC, at least one ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..." | ||
| Vol 6, No 5 (2010) | POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN | Abstract similar documents |
| A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta | ||
| "... and their complications is discussed. Results of studies on efficacy of magnesium and potassium drugs in cardiology ..." | ||
| Vol 16, No 4 (2020) | From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases | Abstract similar documents |
| P. A. Lebedev, A. A. Garanin | ||
| "... scientists, in particular academician A.L. Myasnikov, in the development and creation of a combined drug ..." | ||
| Vol 7, No 1 (2011) | THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY | Abstract similar documents |
| V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev | ||
| "... half of the patients received the drugs in reverse order. Antiplatelet activity of Plavix and Egitromb ..." | ||
| Vol 10, No 4 (2014) | QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER | Abstract similar documents |
| A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov | ||
| "... register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current ..." | ||
| Vol 14, No 6 (2018) | Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk | Abstract PDF (Eng) similar documents |
| O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk | ||
| "... . A retrospective cohort study of real clinical practice of prescribing antihypertensive drugs according to 255 ..." | ||
| Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... combinations (SPC) of antihypertensive drugs. Methods. At the first phase of the study, according ..." | ||
| Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
| O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
| "... Цель. Изучить долгосрочную динамику показателей сосудистого ремоделирования у больных артериальной ..." | ||
| Vol 19, No 2 (2023) | Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease | Abstract similar documents |
| E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina | ||
| "... and 12 months after drug and non-drug secondary prophylaxis according to clinical guidelines. Material ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... with the use of even high doses of statins, which requires its enhancement by other drugs. The article ..." | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... agents were withdrawn 3 weeks before study start (wash-out period). Study drugs were distributed ..." | ||
| Vol 11, No 3 (2015) | EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER) | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, A. V. Fokina, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov | ||
| "... of prescription of drugs with proven efficacy and irrational choice of preventive therapy. Median of treatment ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD ..." | ||
| Vol 14, No 6 (2018) | Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov | ||
| "... Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation ..." | ||
| Vol 17, No 4 (2021) | Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index – What We Know and What We Strive for | Abstract similar documents |
| A. N. Sumin, A. V. Shcheglova | ||
| "... and their risk factors. The results of studies on the effect of drug therapy and measures to control risk factors ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... and polypharmacy that increase the risk of adverse reactions due to the use of both statins and their drug-drug ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... гипертензией (АГ) 1-2-ой степени с повышенным риском сердечно-сосудистых осложнений. Материал и методы ..." | ||
| Vol 11, No 5 (2015) | News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko | ||
| Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
| "... drugs of ACE inhibitor and diuretic, “Noliprel forte” (NF) and “Capozide” (CA), in hypertensive high ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... to the chronic course of primary headache, and effective treatment of HT with antihypertensive drugs ..." | ||
| Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
| V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
| "... choice between original and generic drugs is discussed taking into account efficacy and safety ratio. ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... drug should not only have an adequate hypoglycemic effect, but also have a number of cardioprotective ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... of magnesium deficiency is realized using magnesium-containing drugs, for example magnesium orotate, having ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... resistance, obesity, dyslipidemia is also covered. The evidence base for the use of telmisartan as a drug ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... ), worth special noticing in the classes of sartans and thiazide diuretics, since both drugs have a long ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... convincing evidence base for the use of this class of drugs in the perioperative period that was the basis ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... effects of both its ATC class and drugs of previous generations. Its high antihypertensive activity ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... of antihypertensive drugs and their ability to prevent diabetes onset are compared. Ramipril three years therapy ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (ACE) inhibitors keep important ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... and severity of supraventricular arrhythmias. There is also a lot of evidence of the influence of both non-drug ..." | ||
| Vol 9, No 5 (2013) | LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY | Abstract similar documents |
| O. I. Afanasieva, S. N. Pokrovsky | ||
| "... Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism ..." | ||
| Vol 7, No 5 (2011) | DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) | Abstract similar documents |
| V. M. Provotorov, I. Shevchenko, R. Islamov | ||
| "... in 2007 no one patient received this therapy because of thrombolytic drugs absence. Only 39.4% of patients ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... practice remain the non-assignment of these drugs to patients who have indications for such therapy ..." | ||
| Vol 14, No 4 (2018) | Main Approaches to Assessing the Quality of Drug Therapy in Cardiology | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, N. A. Komkova, N. A. Dmitrieva, O. A. Drapkina | ||
| "... A competent choice of drug therapy in a specific clinical situation is a difficult and important ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often ..." | ||
| Vol 18, No 4 (2022) | Uric Acid as a Risk Factor for Cardiovascular Diseases | Abstract similar documents |
| A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze | ||
| "... -drug ways to reduce the level of uric acid in the blood are considered. From non-drug methods ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... (Nifecard XL, LEK) 30 mg once daily (OD) was prescribed as start antihypertensive drug. Hydrochlorothiazide ..." | ||
| Vol 14, No 3 (2018) | STUDY OF ADHERENCE TO DRUG THERAPY OF PATIENTS WITH CARDIOVASCULAR DISEASES IN DISTRICT HOSPITAL OF SMALL TOWN IN SARATOV REGION AND IN CARDIOLOGY DEPARTMENT OF UNIVERSITY CLINIC IN SARATOV | Abstract similar documents |
| Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova | ||
| "... Aim. To study the relation of various factors with adherence to long-term drug therapy in patients ..." | ||
| Vol 17, No 6 (2021) | Drug-Induced Atrial Fibrillation / Atrial Flutter | Abstract similar documents |
| O. D Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, A. E. Vorobieva, D. I. Bakhteeva, S. P. Korchagina, O. V. Bondarets, N. D. Boyko, D. A. Sychev | ||
| "... Drug-induced atrial fibrillation / flutter (DIAF) is a serious and potentially life-threatening ..." | ||
| Vol 14, No 6 (2018) | The Impact of Valsartan/Amlodipine Single-Pill Combination on Blood Pressure and Vascular Stiffness in Patients with Grade 1-2 Essential Arterial Hypertension | Abstract PDF (Eng) similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| Vol 15, No 2 (2019) | Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics | Abstract similar documents |
| G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov | ||
| "... the triglycerides concentration is their level more than 2.3 mmol/l. Statins are drugs of choice aimed to decrease ..." | ||
| Vol 13, No 5 (2017) | EFFECT OF LISINOPRIL ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS | Abstract similar documents |
| O. L. Sarkisova, N. V. Rebrova, I. I. Bogomolova, E. A. Anisimova, R. S. Karpov, V. F. Mordovin, T. G. Khruleva | ||
| "... of RA. All patients received methotrexate as the basic anti-inflammatory drug, 12 (60%) patients ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... in the tactics of antihypertensive therapy (dose reduction, drug withdrawal or replacement) and changes in target ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... Aim: to evaluate efficiency and safety of the combined antihypertensive drug Lozap Plus (50 mg ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... drug of simvastatin, Zocor, in patients with hyperlipidaemia in short-term study. Material and methods ..." | ||
| Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
| N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
| "... Aim. Analysis of drug-induced bradiarrhythmia (DIB) causes and predisposing factors, followed ..." | ||
| Vol 16, No 6 (2020) | Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences? | Abstract similar documents |
| A. I. Kochetkov | ||
| "... of the first line antihypertensive drugs, which are equivalent in their effectiveness to other main ..." | ||
| Vol 16, No 3 (2020) | Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations? | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova | ||
| "... of arterial hypertension was a conclusion about the need to use a double combination of antihypertensive drugs ..." | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... measurement to poor adherence to therapy and abuse of short-acting antihypertensive drugs) affect the assessed ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... effects of colchicine, a drug that can improve cardiovascular outcomes in patients with proven ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... , госпитализированных по поводу острых сердечно-сосудистых осложнений (ССО), пациентов с ишемической болезнью сердца ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... ? Authors compare these drug classes (mechanism of action, indications, evidense base of clinical trails ..." | ||
| Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... the physiological pregnancy. Experimental and clinical data allows using drugs of magnesium in preventing ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... . The evidence base of modern drugs for preventing the development of cardiovascular complications ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... and biochemical activity) and also it describes the main directions of drug therapy, taking into account ..." | ||
| Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| K. A. Gyamdzhyan, M. L. Maksimov | ||
| "... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..." | ||
| Vol 16, No 3 (2020) | Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs | Abstract similar documents |
| O. V. Gaisenok | ||
| "... drugs from the standpoint of rational pharmacotherapy. Particular attention is paid to drug interactions ..." | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... , and HOPE with ramipril 10 mg. That became the ground of inclusion of these drugs into recommendations ..." | ||
| Vol 8, No 6 (2012) | SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... The most pressing issues of the secondary drug prevention of the most common cardiovascular ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... international guidelines, foreign and web-journals, evaluate higher non-drug approaches to prevention ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... cardiovascular risk and the frequency of prescribing drugs that lower serum uric acid (sUA) levels in real ..." | ||
| Vol 8, No 1 (2012) | COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY | Abstract similar documents |
| E. V. Strokova, E. A. Naumova, J. G. Shvarts | ||
| "... pirlindol, while patients of control group did not receive this drug. Compliance to cardiovascular ..." | ||
| Vol 13, No 5 (2017) | CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM | Abstract similar documents |
| V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova | ||
| "... of antihypertensive drug intake. The new findings concerning a high prognostic value of the night-time blood pressure ..." | ||
| Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... The article is devoted to modern ideas about the role of drug interactions as a factor affecting ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... , antibacterial drugs, pro- and prebiotics are successfully used as tools to correct the structure of the gut ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... . The article contains data from a number of studies showing that varenicline is an effective and safe drug ..." | ||
| Vol 8, No 1 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 | Abstract similar documents |
| V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
| "... от сердечно-сосудистых заболеваний в экономически развитых и развивающихся странах мира. Несмотря на ..." | ||
| Vol 8, No 2 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 | Abstract similar documents |
| V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
| "... от сердечно-сосудистых заболеваний в экономически развитых и развивающихся странах мира. Несмотря на ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... in the private pharmacies. Data were obtained for both original drug and appropriate generics. A list of 25 ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... carotid IMT should have an effect on the choice of hypolipidemic drug and intensity of treatment. However ..." | ||
| 1 - 100 of 1195 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
